The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression
Clinical trial NCT06708156 · RECRUITING
Trial details
- NCT number
- NCT06708156
- Sponsor
- Oupushifang Pharmaceutical Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-15
- Primary completion
- 2026-12-31
- Enrollment
- 606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.